{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:02:32Z","timestamp":1789635752854,"version":"4.0.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Nature Science Foundation of Shanxi Province","award":["202103021224412"],"award-info":[{"award-number":["202103021224412"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-026-02104-1","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:39:05Z","timestamp":1782380345000},"page":"4055-4069","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FASN Promotes Malignant Progression of Bladder Cancer by Regulating Lipid Metabolism via the ERK\/PPAR Pathway"],"prefix":"10.1007","volume":"84","author":[{"given":"Liang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishuang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuedong","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"1","key":"2104_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41388-023-02876-3","volume":"43","author":"M Ramal","year":"2024","unstructured":"Ramal, M., Corral, S., Kalisz, M., et al. (2024). The urothelial gene regulatory network: understanding biology to improve bladder cancer management. Oncogene, 43(1), 1\u201321.","journal-title":"Oncogene"},{"issue":"3","key":"2104_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F., Laversanne, M., Sung, H., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. C Ca: A Cancer Journal For Clinicians, 74(3), 229\u2013263.","journal-title":"C Ca: A Cancer Journal For Clinicians"},{"issue":"1","key":"2104_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12967-025-06138-6","volume":"23","author":"J Li","year":"2025","unstructured":"Li, J., Jiang, Y., Ma, M., et al. (2025). Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics. J Transl Med, 23(1), 135.","journal-title":"J Transl Med"},{"issue":"22","key":"2104_CR4","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1200\/JCO.22.02762","volume":"41","author":"JP Stein","year":"2023","unstructured":"Stein, J. P., Lieskovsky, G., Cote, R., et al. (2023). Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients. Journal Of Clinical Oncology, 41(22), 3772\u20133781.","journal-title":"Journal Of Clinical Oncology"},{"key":"2104_CR5","doi-asserted-by":"publisher","first-page":"156273","DOI":"10.1016\/j.metabol.2025.156273","volume":"169","author":"Y Lu","year":"2025","unstructured":"Lu, Y., Chen, L., Lin, Y., et al. (2025). Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor. Metabolism, 169, 156273.","journal-title":"Metabolism"},{"issue":"4","key":"2104_CR6","doi-asserted-by":"publisher","first-page":"101376","DOI":"10.1016\/j.gendis.2024.101376","volume":"12","author":"WSA Fu","year":"2025","unstructured":"Fu, W. S. A., & Dai, H. (2025). Lipid metabolism involved in progression and drug resistance of breast cancer. Genes Dis, 12(4), 101376.","journal-title":"Genes Dis"},{"issue":"4","key":"2104_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/path.6052","volume":"259","author":"K Cao","year":"2023","unstructured":"Cao, K., Zhang, T., Li, Z., et al. (2023). Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia. The Journal Of Pathology, 259(4), 388\u2013401.","journal-title":"The Journal Of Pathology"},{"issue":"3","key":"2104_CR8","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jhep.2025.02.045","volume":"83","author":"S Zhou","year":"2025","unstructured":"Zhou, S., Zhang, L., You, Y., et al. (2025). eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma. Journal Of Hepatology, 83(3), 712\u2013728.","journal-title":"Journal Of Hepatology"},{"issue":"1","key":"2104_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-024-01962-8","volume":"23","author":"T Jiang","year":"2024","unstructured":"Jiang, T., Qi, J., Xue, Z., et al. (2024). The m(6)A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN. Molecular Cancer, 23(1), 55.","journal-title":"Molecular Cancer"},{"issue":"1","key":"2104_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12943-024-02195-5","volume":"23","author":"Y Mo","year":"2024","unstructured":"Mo, Y., Han, Y., Chen, Y., et al. (2024). ZDHHC20 mediated S-palmitoylation of fatty acid synthase (FASN) promotes hepatocarcinogenesis. Molecular Cancer, 23(1), 274.","journal-title":"Molecular Cancer"},{"issue":"5","key":"2104_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41419-022-04926-2","volume":"13","author":"Q Du","year":"2022","unstructured":"Du, Q., Liu, P., Zhang, C., et al. (2022). FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis. Cell Death And Disease, 13(5), 488.","journal-title":"Cell Death And Disease"},{"issue":"1","key":"2104_CR12","doi-asserted-by":"publisher","first-page":"100721","DOI":"10.1016\/j.jlr.2024.100721","volume":"66","author":"Z Deng","year":"2024","unstructured":"Deng, Z., Liu, L., Xie, G., et al. (2024). Hsp90\u03b1 promotes lipogenesis by stabilizing FASN and promoting FASN transcription via LXR\u03b1 in hepatocellular carcinoma. Journal Of Lipid Research, 66(1), 100721.","journal-title":"Journal Of Lipid Research"},{"issue":"1","key":"2104_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","volume":"8","author":"W Wei","year":"2023","unstructured":"Wei, W., Qin, B., Wen, W., et al. (2023). FBXW7\u03b2 loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth. Signal Transduct Target Ther, 8(1), 187.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2104_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12967-024-04867-8","volume":"22","author":"L Zhou","year":"2024","unstructured":"Zhou, L., Du, K., Dai, Y., et al. (2024). Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells reveals the FASN gene as a therapeutic for bladder cancer. J Transl Med, 22(1), 55.","journal-title":"J Transl Med"},{"issue":"13","key":"2104_CR15","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","volume":"29","author":"W Kelly","year":"2023","unstructured":"Kelly, W., Diaz Duque, A. E., Michalek, J., et al. (2023). Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma. Clinical Cancer Research, 29(13), 2419\u20132425.","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"2104_CR16","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1002\/jcp.27129","volume":"234","author":"T Tao","year":"2019","unstructured":"Tao, T., Su, Q., Xu, S., et al. (2019). Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT\/mTOR\/SREBP-1c axis. Journal Of Cellular Physiology, 234(3), 3088\u20133104.","journal-title":"Journal Of Cellular Physiology"},{"issue":"7","key":"2104_CR17","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ccell.2025.04.002","volume":"43","author":"J Guo","year":"2025","unstructured":"Guo, J., Li, N., Liu, Q., et al. (2025). KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy. Cancer Cell, 43(7), 1261\u20131278e1210.","journal-title":"Cancer Cell"},{"key":"2104_CR18","doi-asserted-by":"crossref","unstructured":"Yang, T., Guo, L., & Kong, S. (2025). The lncRNA MIR4435-2HG modulates bladder cancer progression and ferroptosis through the IQGAP3\/Ras\/ERK\/CREB pathway. Faseb J, 39(20), e71119.","DOI":"10.1096\/fj.202500745RR"},{"issue":"1","key":"2104_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2024.2434209","volume":"19","author":"Z Liu","year":"2025","unstructured":"Liu, Z., & Pu, X. (2025). Orosomucoid 1 interacts with S100A12 and activates ERK signalling to expedite the advancement of bladder cancer. Cell Adh Migr, 19(1), 1\u201311.","journal-title":"Cell Adh Migr"},{"issue":"8","key":"2104_CR20","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41419-023-06090-7","volume":"14","author":"J Shi","year":"2023","unstructured":"Shi, J., Miao, D., Lv, Q., et al. (2023). The m6A modification-mediated OGDHL exerts a tumor suppressor role in ccRCC by downregulating FASN to inhibit lipid synthesis and ERK signaling. Cell Death And Disease, 14(8), 560.","journal-title":"Cell Death And Disease"},{"issue":"1","key":"2104_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12944-025-02490-0","volume":"24","author":"L Wang","year":"2025","unstructured":"Wang, L., Wei, L., Chen, X., et al. (2025). Arachidonic acid suppresses lung cancer cell growth and modulates lipid metabolism and the ERK\/PPAR\u03b3 signaling pathway. Lipids In Health And Disease, 24(1), 114.","journal-title":"Lipids In Health And Disease"},{"issue":"6","key":"2104_CR22","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.7150\/thno.82920","volume":"13","author":"K Yang","year":"2023","unstructured":"Yang, K., Wang, X., Song, C., et al. (2023). The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics, 13(6), 1774\u20131808.","journal-title":"Theranostics"},{"issue":"9","key":"2104_CR23","first-page":"2196","volume":"18","author":"I Kawahara","year":"2024","unstructured":"Kawahara, I., Yoshino, H., Fukumoto, W., et al. (2024). Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine- and cisplatin-resistant models. Molecular Oncology, 18(9), 2196\u20132211.","journal-title":"Molecular Oncology"},{"issue":"15","key":"2104_CR24","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.7150\/ijbs.123647","volume":"21","author":"Z Li","year":"2025","unstructured":"Li, Z., Yang, L., Li, W., et al. (2025). Metabolic Reprogramming in Urological Tumors: New Perspectives from Tumor Metabolic Phenotypes to Therapeutic Targets. International Journal Of Biological Sciences, 21(15), 6926\u20136951.","journal-title":"International Journal Of Biological Sciences"},{"issue":"1","key":"2104_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41419-025-08369-3","volume":"17","author":"S Liu","year":"2025","unstructured":"Liu, S., Liu, T., & Yang, C. (2025). Cytoskeletal protein KRT14 governs cisplatin resistance by modulating eIF4H-dependent ACOX2 translation and lipid metabolism in bladder cancer. Cell Death And Disease, 17(1), 134.","journal-title":"Cell Death And Disease"},{"issue":"1","key":"2104_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41420-023-01540-9","volume":"9","author":"X Li","year":"2023","unstructured":"Li, X., Su, W., Wu, H., et al. (2023). FOXM1 maintains fatty acid homoeostasis through the SET7-H3K4me1-FASN axis. Cell Death Discov, 9(1), 310.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2104_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.7150\/thno.83051","volume":"14","author":"L Wang","year":"2024","unstructured":"Wang, L., Zhu, H., Shi, Z., et al. (2024). MK8722 initiates early-stage autophagy while inhibiting late-stage autophagy via FASN-dependent reprogramming of lipid metabolism. Theranostics, 14(1), 75\u201395.","journal-title":"Theranostics"},{"issue":"1","key":"2104_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41420-025-02409-9","volume":"11","author":"X Liu","year":"2025","unstructured":"Liu, X., Lu, J., Ni, X., et al. (2025). FASN promotes lipid metabolism and progression in colorectal cancer via the SP1\/PLA2G4B axis. Cell Death Discov, 11(1), 122.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2104_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12967-023-03874-5","volume":"21","author":"U Chianese","year":"2023","unstructured":"Chianese, U., Papulino, C., Ali, A., et al. (2023). FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma. J Transl Med, 21(1), 32.","journal-title":"J Transl Med"},{"issue":"10","key":"2104_CR30","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.7150\/ijbs.85285","volume":"19","author":"M Ye","year":"2023","unstructured":"Ye, M., Hu, C., Chen, T., et al. (2023). FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression. International Journal Of Biological Sciences, 19(10), 3115\u20133127.","journal-title":"International Journal Of Biological Sciences"},{"issue":"4","key":"2104_CR31","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s12079-023-00771-w","volume":"17","author":"S Chaturvedi","year":"2023","unstructured":"Chaturvedi, S., Biswas, M., Sadhukhan, S., et al. (2023). Role of EGFR and FASN in breast cancer progression. J Cell Commun Signal, 17(4), 1249\u20131282.","journal-title":"J Cell Commun Signal"},{"issue":"12","key":"2104_CR32","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.7150\/ijbs.101039","volume":"20","author":"B Li","year":"2024","unstructured":"Li, B., Cheng, B., Huang, H., et al. (2024). Darolutamide-mediated phospholipid remodeling induces ferroptosis through the SREBP1-FASN axis in prostate cancer. International Journal Of Biological Sciences, 20(12), 4635\u20134653.","journal-title":"International Journal Of Biological Sciences"},{"issue":"6","key":"2104_CR33","doi-asserted-by":"publisher","first-page":"101592","DOI":"10.1016\/j.xcrm.2024.101592","volume":"5","author":"HZ Guo","year":"2024","unstructured":"Guo, H. Z., Feng, R. X., Zhang, Y. J., et al. (2024). A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML. Cell Rep Med, 5(6), 101592.","journal-title":"Cell Rep Med"},{"issue":"22","key":"2104_CR34","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1158\/0008-5472.CAN-24-4247","volume":"85","author":"Y Dai","year":"2025","unstructured":"Dai, Y., Liu, L., Luo, Y., et al. (2025). Malonyl-CoA Promotes Prostate Cancer Progression and Castration Resistance by Enhancing Lipogenesis and Ran Activation. Cancer Research, 85(22), 4504\u20134520.","journal-title":"Cancer Research"},{"issue":"1","key":"2104_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s40001-025-03654-5","volume":"31","author":"W Zhang","year":"2025","unstructured":"Zhang, W., Fei, X., & Qin, P. (2025). GAB2 regulates lipid metabolism by activating the MEK\/ERK\/c-Myc pathway: impact on renal cell carcinoma progression. European Journal Of Medical Research, 31(1), 143.","journal-title":"European Journal Of Medical Research"},{"issue":"1","key":"2104_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-025-02238-5","volume":"24","author":"C Li","year":"2025","unstructured":"Li, C., Xiong, L., Yang, Y., et al. (2025). Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPAR\u03b1-mediated fatty acid oxidation. Molecular Cancer, 24(1), 34.","journal-title":"Molecular Cancer"},{"issue":"1","key":"2104_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00438-025-02243-9","volume":"300","author":"X Tian","year":"2025","unstructured":"Tian, X., Bai, X., Han, Y., et al. (2025). PPAR \u03b3 changing ALDH1A3 content to regulate lipid metabolism and inhibit lung cancer cell growth. Molecular Genetics And Genomics, 300(1), 41.","journal-title":"Molecular Genetics And Genomics"},{"key":"2104_CR38","doi-asserted-by":"publisher","first-page":"114616","DOI":"10.1016\/j.intimp.2025.114616","volume":"155","author":"A Singh","year":"2025","unstructured":"Singh, A., & Chaudhary, R. (2025). Potentials of peroxisome proliferator-activated receptor (PPAR) \u03b1, \u03b2\/\u03b4, and \u03b3: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases. International Immunopharmacology, 155, 114616.","journal-title":"International Immunopharmacology"},{"issue":"5","key":"2104_CR39","doi-asserted-by":"publisher","first-page":"763","DOI":"10.5713\/ab.21.0371","volume":"35","author":"S Pan","year":"2022","unstructured":"Pan, S., Chen, Y., Zhang, L., et al. (2022). Curcumin represses lipid accumulation through inhibiting ERK1\/2-PPAR-\u03b3 signaling pathway and triggering apoptosis in porcine subcutaneous preadipocytes. Anim Biosci, 35(5), 763\u2013777.","journal-title":"Anim Biosci"},{"issue":"6","key":"2104_CR40","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s10528-022-10223-6","volume":"60","author":"G Li","year":"2022","unstructured":"Li, G., Wang, Y., Guo, X. B., et al. (2022). CDC42 Regulates Cell Proliferation and Apoptosis in Bladder Cancer via the IQGAP3-Mediated Ras\/ERK Pathway. Biochemical Genetics, 60(6), 2383\u20132398.","journal-title":"Biochemical Genetics"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02104-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02104-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02104-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:16:09Z","timestamp":1789632969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02104-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2104"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02104-1","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"9 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The clinical trial was approved by the Clinical Research Ethics Committee of the First Hospital of Shanxi Medical University (Ethics No. [2022](K056)). The animal experiments were approved by the Experimental Animal Welfare and Ethics Committee of Shanxi Medical University (Ethics No. SYDL2023008). All methods were performed in accordance with the relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}